Annual EBITDA:
-$285.40M-$112.56M(-65.13%)Summary
- As of today, AKRO annual EBITDA is -$285.40 million, with the most recent change of -$112.56 million (-65.13%) on December 31, 2024.
- During the last 3 years, AKRO annual EBITDA has fallen by -$184.76 million (-183.58%).
- AKRO annual EBITDA is now -6153.40% below its all-time high of -$4.56 million, reached on December 31, 2017.
Performance
AKRO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$80.87M+$9000.00(+0.01%)Summary
- As of today, AKRO quarterly EBITDA is -$80.87 million, with the most recent change of +$9000.00 (+0.01%) on June 30, 2025.
- Over the past year, AKRO quarterly EBITDA has dropped by -$15.13 million (-23.02%).
- AKRO quarterly EBITDA is now -19109.74% below its all-time high of -$421.00 thousand, reached on March 31, 2018.
Performance
AKRO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$321.47M-$15.13M(-4.94%)Summary
- As of today, AKRO TTM EBITDA is -$321.47 million, with the most recent change of -$15.13 million (-4.94%) on June 30, 2025.
- Over the past year, AKRO TTM EBITDA has dropped by -$87.29 million (-37.28%).
- AKRO TTM EBITDA is now -58884.77% below its all-time high of -$545.00 thousand, reached on December 1, 2017.
Performance
AKRO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AKRO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -65.1% | -23.0% | -37.3% |
| 3Y3 Years | -183.6% | -193.8% | -191.8% |
| 5Y5 Years | -525.5% | -393.1% | -384.0% |
AKRO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -183.6% | at low | -219.0% | +1.0% | -179.8% | at low |
| 5Y | 5-Year | -525.5% | at low | -436.8% | +1.0% | -384.0% | at low |
| All-Time | All-Time | -6153.4% | at low | >-9999.0% | +1.0% | >-9999.0% | at low |
AKRO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$80.87M(+0.0%) | -$321.47M(-4.9%) |
| Mar 2025 | - | -$80.88M(-3.7%) | -$306.33M(-7.3%) |
| Dec 2024 | -$285.40M(-65.1%) | -$78.01M(+4.5%) | -$285.40M(-6.0%) |
| Sep 2024 | - | -$81.70M(-24.3%) | -$269.27M(-15.0%) |
| Jun 2024 | - | -$65.74M(-9.7%) | -$234.17M(-14.8%) |
| Mar 2024 | - | -$59.95M(+3.1%) | -$203.99M(-18.1%) |
| Dec 2023 | -$172.84M(-50.4%) | -$61.87M(-32.7%) | -$172.73M(-26.8%) |
| Sep 2023 | - | -$46.61M(-31.1%) | -$136.21M(-8.4%) |
| Jun 2023 | - | -$35.56M(-24.0%) | -$125.63M(-6.8%) |
| Mar 2023 | - | -$28.68M(-13.1%) | -$117.59M(-2.3%) |
| Dec 2022 | -$114.90M(-14.2%) | -$25.36M(+29.6%) | -$114.90M(+5.8%) |
| Sep 2022 | - | -$36.02M(-30.9%) | -$121.92M(-10.6%) |
| Jun 2022 | - | -$27.53M(-5.9%) | -$110.19M(+1.2%) |
| Mar 2022 | - | -$25.99M(+19.7%) | -$111.56M(-10.9%) |
| Dec 2021 | -$100.64M | -$32.38M(-33.3%) | -$100.64M(-2.7%) |
| Sep 2021 | - | -$24.29M(+16.0%) | -$97.99M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$28.91M(-91.8%) | -$95.19M(-15.1%) |
| Mar 2021 | - | -$15.07M(+49.3%) | -$82.68M(-3.4%) |
| Dec 2020 | -$79.94M(-75.2%) | -$29.72M(-38.3%) | -$79.94M(-20.4%) |
| Sep 2020 | - | -$21.49M(-31.0%) | -$66.42M(-8.5%) |
| Jun 2020 | - | -$16.40M(-33.1%) | -$61.23M(-16.8%) |
| Mar 2020 | - | -$12.32M(+23.9%) | -$52.44M(-14.9%) |
| Dec 2019 | -$45.63M(-231.2%) | -$16.20M(+0.7%) | -$45.63M(-40.8%) |
| Sep 2019 | - | -$16.31M(-114.3%) | -$32.40M(-81.8%) |
| Jun 2019 | - | -$7.61M(-38.0%) | -$17.82M(+5.6%) |
| Mar 2019 | - | -$5.51M(-85.7%) | -$18.87M(-37.0%) |
| Dec 2018 | -$13.78M(-201.9%) | -$2.97M(-71.9%) | -$13.78M(-21.3%) |
| Sep 2018 | - | -$1.73M(+80.1%) | -$11.36M(-17.9%) |
| Jun 2018 | - | -$8.66M(-1957.5%) | -$9.63M(-896.7%) |
| Mar 2018 | - | -$421.00K(+22.8%) | -$966.00K(-77.2%) |
| Dec 2017 | -$4.56M | - | - |
| Dec 2017 | - | -$545.00K | -$545.00K |
FAQ
- What is Akero Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Akero Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Akero Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Akero Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of AKRO is -$285.40M
What is the all-time high annual EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual EBITDA is -$4.56M
What is Akero Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, AKRO annual EBITDA has changed by -$112.56M (-65.13%)
What is Akero Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of AKRO is -$80.87M
What is the all-time high quarterly EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly EBITDA is -$421.00K
What is Akero Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, AKRO quarterly EBITDA has changed by -$15.13M (-23.02%)
What is Akero Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of AKRO is -$321.47M
What is the all-time high TTM EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM EBITDA is -$545.00K
What is Akero Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, AKRO TTM EBITDA has changed by -$87.29M (-37.28%)